Biomedicines (Apr 2023)

Ouabain Reverts CUS-Induced Disruption of the HPA Axis and Avoids Long-Term Spatial Memory Deficits

  • Jacqueline Alves Leite,
  • Ana Maria Orellana,
  • Diana Zukas Andreotti,
  • Amanda Midori Matumoto,
  • Natacha Medeiros de Souza Ports`,
  • Larissa de Sá Lima,
  • Elisa Mitiko Kawamoto,
  • Carolina Demarchi Munhoz,
  • Cristoforo Scavone

DOI
https://doi.org/10.3390/biomedicines11041177
Journal volume & issue
Vol. 11, no. 4
p. 1177

Abstract

Read online

Ouabain (OUA) is a cardiotonic steroid that modulates Na+, K+ -ATPase activity. OUA has been identified as an endogenous substance that is present in human plasma, and it has been shown to be associated with the response to acute stress in both animals and humans. Chronic stress is a major aggravating factor in psychiatric disorders, including depression and anxiety. The present work investigates the effects of the intermittent administration of OUA (1.8 μg/kg) during the chronic unpredictable stress (CUS) protocol in a rat’s central nervous system (CNS). The results suggest that the intermittent OUA treatment reversed CUS-induced HPA axis hyperactivity through a reduction in (i) glucocorticoids levels, (ii) CRH-CRHR1 expression, and by decreasing neuroinflammation with a reduction in iNOS activity, without interfering with the expression of antioxidant enzymes. These changes in both the hypothalamus and hippocampus may reflect in the rapid extinction of aversive memory. The present data demonstrate the ability of OUA to modulate the HPA axis, as well as to revert CUS-induced long-term spatial memory deficits.

Keywords